Click here to get full coverage on Wellington Management Group LLP Trims Holdings in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Wellington Management Group LLP Trims Holdings in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Wellington Management Group LLP Trims Holdings in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline - Stocktwits

KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline  Stocktwits

KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline - Stocktwits

Click here to get full coverage on Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 - Moomoo

Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151  Moomoo

Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 - Moomoo

Click here to get full coverage on KYMR Maintained by Wells Fargo -- Price Target Raised to $151 - GuruFocus

KYMR Maintained by Wells Fargo -- Price Target Raised to $151  GuruFocus

KYMR Maintained by Wells Fargo -- Price Target Raised to $151 - GuruFocus

Click here to get full coverage on Kymera Therapeutics (KYMR) Stock Gets Fair Value Bump After KT 621 Timeline Shift - Yahoo Finance

Kymera Therapeutics (KYMR) Stock Gets Fair Value Bump After KT 621 Timeline Shift  Yahoo Finance

Kymera Therapeutics (KYMR) Stock Gets Fair Value Bump After KT 621 Timeline Shift - Yahoo Finance

Click here to get full coverage on 119,503 Shares in Kymera Therapeutics, Inc. $KYMR Acquired by The Manufacturers Life Insurance Company - MarketBeat

119,503 Shares in Kymera Therapeutics, Inc. $KYMR Acquired by The Manufacturers Life Insurance Company  MarketBeat

119,503 Shares in Kymera Therapeutics, Inc. $KYMR Acquired by The Manufacturers Life Insurance Company - MarketBeat

Click here to get full coverage on Kymera Therapeutics (KYMR) Soars 10.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Kymera Therapeutics (KYMR) Soars 10.0%: Is Further Upside Left in the Stock?  Yahoo Finance

Kymera Therapeutics (KYMR) Soars 10.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on Freestone Grove Partners LP Purchases New Shares in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Freestone Grove Partners LP Purchases New Shares in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Freestone Grove Partners LP Purchases New Shares in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates  Yahoo Finance

Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on 20,000 Shares in Kymera Therapeutics, Inc. $KYMR Purchased by Bamco Inc. NY - MarketBeat

20,000 Shares in Kymera Therapeutics, Inc. $KYMR Purchased by Bamco Inc. NY  MarketBeat

20,000 Shares in Kymera Therapeutics, Inc. $KYMR Purchased by Bamco Inc. NY - MarketBeat

Click here to get full coverage on KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments - Yahoo Finance

KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments  Yahoo Finance

KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments - Yahoo Finance

Click here to get full coverage on Wells Fargo & Company Issues Positive Forecast for Kymera Therapeutics (NASDAQ:KYMR) Stock Price - MarketBeat

Wells Fargo & Company Issues Positive Forecast for Kymera Therapeutics (NASDAQ:KYMR) Stock Price  MarketBeat

Wells Fargo & Company Issues Positive Forecast for Kymera Therapeutics (NASDAQ:KYMR) Stock Price - MarketBeat

Click here to get full coverage on Is Kymera Therapeutics, Inc. (KYMR) a Long-Term Biotech Winner After New Buy Rating and Coverage Launch At Canaccord? - Yahoo Finance

Is Kymera Therapeutics, Inc. (KYMR) a Long-Term Biotech Winner After New Buy Rating and Coverage Launch At Canaccord?  Yahoo Finance

Is Kymera Therapeutics, Inc. (KYMR) a Long-Term Biotech Winner After New Buy Rating and Coverage Launch At Canaccord? - Yahoo Finance

Click here to get full coverage on Proficio Capital Partners LLC Invests $1.27 Million in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Proficio Capital Partners LLC Invests $1.27 Million in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Proficio Capital Partners LLC Invests $1.27 Million in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Kymera Therapeutics (KYMR) Valuation Check After New KT-621 And KT-579 Clinical And Preclinical Progress - Yahoo Finance

Kymera Therapeutics (KYMR) Valuation Check After New KT-621 And KT-579 Clinical And Preclinical Progress  Yahoo Finance

Kymera Therapeutics (KYMR) Valuation Check After New KT-621 And KT-579 Clinical And Preclinical Progress - Yahoo Finance

Click here to get full coverage on Boone Capital Management LLC Purchases Shares of 113,173 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Boone Capital Management LLC Purchases Shares of 113,173 Kymera Therapeutics, Inc. $KYMR  MarketBeat

Boone Capital Management LLC Purchases Shares of 113,173 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength? - Yahoo Finance

Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength?  Yahoo Finance

Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength? - Yahoo Finance

Click here to get full coverage on Kymera Therapeutics, Inc. $KYMR Stock Holdings Increased by Odyssean LLC - MarketBeat

Kymera Therapeutics, Inc. $KYMR Stock Holdings Increased by Odyssean LLC  MarketBeat

Kymera Therapeutics, Inc. $KYMR Stock Holdings Increased by Odyssean LLC - MarketBeat

Click here to get full coverage on Kymera Therapeutics (NASDAQ:KYMR) Upgraded at TD Cowen - MarketBeat

Kymera Therapeutics (NASDAQ:KYMR) Upgraded at TD Cowen  MarketBeat

Kymera Therapeutics (NASDAQ:KYMR) Upgraded at TD Cowen - MarketBeat

Click here to get full coverage on Nicholas Investment Partners LP Invests $6.26 Million in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Nicholas Investment Partners LP Invests $6.26 Million in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Nicholas Investment Partners LP Invests $6.26 Million in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 - 富途牛牛

Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151  富途牛牛

Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 - 富途牛牛

Click here to get full coverage on Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates  Yahoo Finance

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance

Click here to get full coverage on Will Kymera (KYMR) New CMO Hire Quietly Reframe Its Immunology Execution Story? - simplywall.st

Will Kymera (KYMR) New CMO Hire Quietly Reframe Its Immunology Execution Story?  simplywall.st

Will Kymera (KYMR) New CMO Hire Quietly Reframe Its Immunology Execution Story? - simplywall.st

Click here to get full coverage on Kymera Therapeutics, Inc. $KYMR Shares Sold by Bank of America Corp DE - MarketBeat

Kymera Therapeutics, Inc. $KYMR Shares Sold by Bank of America Corp DE  MarketBeat

Kymera Therapeutics, Inc. $KYMR Shares Sold by Bank of America Corp DE - MarketBeat

Click here to get full coverage on How The Kymera Therapeutics (KYMR) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance

How The Kymera Therapeutics (KYMR) Investment Narrative Is Evolving Without New Analyst Targets  Yahoo Finance

How The Kymera Therapeutics (KYMR) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance

Click here to get full coverage on Kymera Therapeutics Inc. (KYMR) Key Financial Ratios – Valuation, Profitability & More - Value Research

Kymera Therapeutics Inc. (KYMR) Key Financial Ratios – Valuation, Profitability & More  Value Research

Kymera Therapeutics Inc. (KYMR) Key Financial Ratios – Valuation, Profitability & More - Value Research

Click here to get full coverage on Merck & Co. Inc. Takes Position in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Merck & Co. Inc. Takes Position in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Merck & Co. Inc. Takes Position in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on 5,538,210 Shares in Kymera Therapeutics, Inc. $KYMR Purchased by BlackRock Inc. - MarketBeat

5,538,210 Shares in Kymera Therapeutics, Inc. $KYMR Purchased by BlackRock Inc.  MarketBeat

5,538,210 Shares in Kymera Therapeutics, Inc. $KYMR Purchased by BlackRock Inc. - MarketBeat

Click here to get full coverage on Nan Fung Group Holdings Ltd Invests $3.54 Billion in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Nan Fung Group Holdings Ltd Invests $3.54 Billion in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Nan Fung Group Holdings Ltd Invests $3.54 Billion in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on 12,083 Shares in Kymera Therapeutics, Inc. $KYMR Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat

12,083 Shares in Kymera Therapeutics, Inc. $KYMR Bought by B. Metzler seel. Sohn & Co. AG  MarketBeat

12,083 Shares in Kymera Therapeutics, Inc. $KYMR Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat

Click here to get full coverage on Connor Clark & Lunn Investment Management Ltd. Buys Shares of 149,908 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Connor Clark & Lunn Investment Management Ltd. Buys Shares of 149,908 Kymera Therapeutics, Inc. $KYMR  MarketBeat

Connor Clark & Lunn Investment Management Ltd. Buys Shares of 149,908 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Assessing Kymera Therapeutics (KYMR) Valuation After Recent Share Price Rebound - Yahoo Finance

Assessing Kymera Therapeutics (KYMR) Valuation After Recent Share Price Rebound  Yahoo Finance

Assessing Kymera Therapeutics (KYMR) Valuation After Recent Share Price Rebound - Yahoo Finance

Click here to get full coverage on KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug - Yahoo Finance

KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug  Yahoo Finance

KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug - Yahoo Finance

Click here to get full coverage on Brookline Capital Markets Increases Price Target for Kymera Therapeutics (KYMR) - Yahoo Finance

Brookline Capital Markets Increases Price Target for Kymera Therapeutics (KYMR)  Yahoo Finance

Brookline Capital Markets Increases Price Target for Kymera Therapeutics (KYMR) - Yahoo Finance

Click here to get full coverage on KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug - Yahoo Finance

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug  Yahoo Finance

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug - Yahoo Finance

Click here to get full coverage on Eagle Health Investments LP Buys Shares of 166,148 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Eagle Health Investments LP Buys Shares of 166,148 Kymera Therapeutics, Inc. $KYMR  MarketBeat

Eagle Health Investments LP Buys Shares of 166,148 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on A Look At Kymera Therapeutics (KYMR) Valuation After Fast Track News And Gilead Collaboration Progress - Yahoo Finance

A Look At Kymera Therapeutics (KYMR) Valuation After Fast Track News And Gilead Collaboration Progress  Yahoo Finance

A Look At Kymera Therapeutics (KYMR) Valuation After Fast Track News And Gilead Collaboration Progress - Yahoo Finance

Click here to get full coverage on Is Kymera (KYMR) the Best Performing American Stock in June 2026? - Yahoo Finance

Is Kymera (KYMR) the Best Performing American Stock in June 2026?  Yahoo Finance

Is Kymera (KYMR) the Best Performing American Stock in June 2026? - Yahoo Finance

Click here to get full coverage on State of Wyoming Purchases New Position in Kymera Therapeutics, Inc. $KYMR - MarketBeat

State of Wyoming Purchases New Position in Kymera Therapeutics, Inc. $KYMR  MarketBeat

State of Wyoming Purchases New Position in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Kymera Therapeutics(KYMR.US) Director Sells US$48.59 Million in Common Stock - Moomoo

Kymera Therapeutics(KYMR.US) Director Sells US$48.59 Million in Common Stock  Moomoo

Kymera Therapeutics(KYMR.US) Director Sells US$48.59 Million in Common Stock - Moomoo

Click here to get full coverage on Kymera Therapeutics Stock (KYMR) Opinions on Director's Substantial Share Sale - Quiver Quantitative

Kymera Therapeutics Stock (KYMR) Opinions on Director's Substantial Share Sale  Quiver Quantitative

Kymera Therapeutics Stock (KYMR) Opinions on Director's Substantial Share Sale - Quiver Quantitative

Click here to get full coverage on KYMR Forecast — Price Target — Prediction for 2027 - TradingView

KYMR Forecast — Price Target — Prediction for 2027  TradingView

KYMR Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Consensus Rating of "Moderate Buy" from Brokerages  MarketBeat

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Click here to get full coverage on Kymera Therapeutics (KYMR) Stock Faces A Revenue Durability Reckoning - simplywall.st

Kymera Therapeutics (KYMR) Stock Faces A Revenue Durability Reckoning  simplywall.st

Kymera Therapeutics (KYMR) Stock Faces A Revenue Durability Reckoning - simplywall.st

Click here to get full coverage on How The Kymera Therapeutics (KYMR) Story Is Shifting Around KT-621 And Degrader Potential - Yahoo Finance

How The Kymera Therapeutics (KYMR) Story Is Shifting Around KT-621 And Degrader Potential  Yahoo Finance

How The Kymera Therapeutics (KYMR) Story Is Shifting Around KT-621 And Degrader Potential - Yahoo Finance

Click here to get full coverage on Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript - The Globe and Mail

Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript  The Globe and Mail

Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript - The Globe and Mail

Click here to get full coverage on Kymera Therapeutics (KYMR) Stock Looks Fully Priced After A 405% Run - simplywall.st

Kymera Therapeutics (KYMR) Stock Looks Fully Priced After A 405% Run  simplywall.st

Kymera Therapeutics (KYMR) Stock Looks Fully Priced After A 405% Run - simplywall.st

Click here to get full coverage on TimesSquare Capital Management LLC Purchases Shares of 157,327 Kymera Therapeutics, Inc. $KYMR - MarketBeat

TimesSquare Capital Management LLC Purchases Shares of 157,327 Kymera Therapeutics, Inc. $KYMR  MarketBeat

TimesSquare Capital Management LLC Purchases Shares of 157,327 Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Kymera Therapeutics Stock 8-Day Winning Spree: Stock Climbs 14% - Trefis

Kymera Therapeutics Stock 8-Day Winning Spree: Stock Climbs 14%  Trefis

Kymera Therapeutics Stock 8-Day Winning Spree: Stock Climbs 14% - Trefis

Click here to get full coverage on FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma - Yahoo Finance

FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma  Yahoo Finance

FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma - Yahoo Finance

Click here to get full coverage on T. Rowe Price Associates (KYMR) reports 8.6% stake in Kymera Therapeutics - Stock Titan

T. Rowe Price Associates (KYMR) reports 8.6% stake in Kymera Therapeutics  Stock Titan

T. Rowe Price Associates (KYMR) reports 8.6% stake in Kymera Therapeutics - Stock Titan

Click here to get full coverage on Atlas Venture funds (KYMR) report 3.4% beneficial stake in Kymera Therapeutics - Stock Titan

Atlas Venture funds (KYMR) report 3.4% beneficial stake in Kymera Therapeutics  Stock Titan

Atlas Venture funds (KYMR) report 3.4% beneficial stake in Kymera Therapeutics - Stock Titan

Click here to get full coverage on Kymera stock climbs on expedited eczema study (KYMR:NASDAQ) - Seeking Alpha

Kymera stock climbs on expedited eczema study (KYMR:NASDAQ)  Seeking Alpha

Kymera stock climbs on expedited eczema study (KYMR:NASDAQ) - Seeking Alpha

Click here to get full coverage on KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration - Yahoo Finance

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration  Yahoo Finance

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration - Yahoo Finance

Click here to get full coverage on Insider Sale: Director at $KYMR Sells 9,584 Shares | KYMR Stock News - Quiver Quantitative

Insider Sale: Director at $KYMR Sells 9,584 Shares | KYMR Stock News  Quiver Quantitative

Insider Sale: Director at $KYMR Sells 9,584 Shares | KYMR Stock News - Quiver Quantitative

Click here to get full coverage on Deutsche Bank AG Makes New $12.16 Million Investment in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Deutsche Bank AG Makes New $12.16 Million Investment in Kymera Therapeutics, Inc. $KYMR  MarketBeat

Deutsche Bank AG Makes New $12.16 Million Investment in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Click here to get full coverage on Insider Sale: Chief Executive Officer of $KYMR Sells 50,000 Shares - Quiver Quantitative

Insider Sale: Chief Executive Officer of $KYMR Sells 50,000 Shares  Quiver Quantitative

Insider Sale: Chief Executive Officer of $KYMR Sells 50,000 Shares - Quiver Quantitative

Click here to get full coverage on Why Is KYMR Stock Up 54% Today? - Stocktwits

Why Is KYMR Stock Up 54% Today?  Stocktwits

Why Is KYMR Stock Up 54% Today? - Stocktwits

Click here to get full coverage on KYMR Q2'26 Earnings: revenue estimate is 32.16M USD - TradingView

KYMR Q2'26 Earnings: revenue estimate is 32.16M USD  TradingView

KYMR Q2'26 Earnings: revenue estimate is 32.16M USD - TradingView

Click here to get full coverage on Kymera Therapeutics (NASDAQ:KYMR) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat

Kymera Therapeutics (NASDAQ:KYMR) Sees Unusually-High Trading Volume - Still a Buy?  MarketBeat

Kymera Therapeutics (NASDAQ:KYMR) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat

Click here to get full coverage on Insider Sale: Chief Financial Officer of $KYMR Sells 4,110 Shares - Quiver Quantitative

Insider Sale: Chief Financial Officer of $KYMR Sells 4,110 Shares  Quiver Quantitative

Insider Sale: Chief Financial Officer of $KYMR Sells 4,110 Shares - Quiver Quantitative

Click here to get full coverage on Stocks making the biggest moves midday: BlackBerry, Kymera Therapeutics, Apple, Wendy's & more - CNBC

Stocks making the biggest moves midday: BlackBerry, Kymera Therapeutics, Apple, Wendy's & more  CNBC

Stocks making the biggest moves midday: BlackBerry, Kymera Therapeutics, Apple, Wendy's & more - CNBC

Click here to get full coverage on Kymera Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-08-05 - Seeking Alpha

Kymera Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-08-05  Seeking Alpha

Kymera Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-08-05 - Seeking Alpha

Click here to get full coverage on Kymera Therapeutics (KYMR) Soars As Pipeline And Partnerships Advance - timothysykes.com

Kymera Therapeutics (KYMR) Soars As Pipeline And Partnerships Advance  timothysykes.com

Kymera Therapeutics (KYMR) Soars As Pipeline And Partnerships Advance - timothysykes.com

Click here to get full coverage on Kymera Therapeutics (NASDAQ:KYMR) Releases Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat

Kymera Therapeutics (NASDAQ:KYMR) Releases Earnings Results, Beats Estimates By $0.09 EPS  MarketBeat

Kymera Therapeutics (NASDAQ:KYMR) Releases Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat

Click here to get full coverage on KYMR (NASDAQ: KYMR) Rule 144 notice — 66,893 shares; prior 10b5-1 sales listed - Stock Titan

KYMR (NASDAQ: KYMR) Rule 144 notice — 66,893 shares; prior 10b5-1 sales listed  Stock Titan

KYMR

Price Chart

Key Statistics

Technicals

About KYMR

Latest News

Wellington Management Group LLP Trims Holdings in Kymera Therapeutics, Inc. $KYMR - MarketBeat

KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline - Stocktwits

Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 - Moomoo

Advanced Charts

Top Gainers

Top Losers